The importance of measuring SARS-CoV-2-specific T-cell responses in an ongoing pandemic
Neutralizing antibodies are considered a correlate of protection against SARS-CoV-2
infection and severe COVID-19, although they are not the only contributing factor to …
infection and severe COVID-19, although they are not the only contributing factor to …
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 …
MH Kyaw, J Spinardi, L Zhang, HML Oh… - Human Vaccines & …, 2023 - Taylor & Francis
Introduction of primary COVID-19 vaccination has helped reduce severe disease and death
caused by SARS-CoV-2 infection. Understanding the protection conferred by heterologous …
caused by SARS-CoV-2 infection. Understanding the protection conferred by heterologous …
Long COVID: the next public health crisis is already on its way
C Yang, SJ Tebbutt - The Lancet Regional Health–Europe, 2023 - thelancet.com
Conservative estimates suggest that over 200 million SARS-CoV-2 infected individuals
worldwide will develop persistent symptoms of COVID-19, also referred to as" long …
worldwide will develop persistent symptoms of COVID-19, also referred to as" long …
Cellular and humoral immune response to a third dose of BNT162b2 COVID-19 vaccine–a prospective observational study
J Herzberg, B Fischer, H Becher, AK Becker… - Frontiers in …, 2022 - frontiersin.org
Background Since the introduction of various vaccines against SARS-CoV-2 at the end of
2020, infection rates have continued to climb worldwide. This led to the establishment of a …
2020, infection rates have continued to climb worldwide. This led to the establishment of a …
The levels of anti-SARS-CoV-2 spike protein IgG antibodies before and after the third dose of vaccination against COVID-19
M Łysek-Gładysińska, M Starz… - Journal of …, 2023 - Taylor & Francis
Purpose The COVID-19 pandemic has been going on for almost three years, and so far,
many preventive and therapeutic strategies have been developed. The issue of subsequent …
many preventive and therapeutic strategies have been developed. The issue of subsequent …
Metabolic adaptations correlated with antibody response after immunization with inactivated SARS-CoV-2 in Brazilian subjects
J de Souza Nogueira… - Journal of Proteome …, 2023 - ACS Publications
The adsorbed vaccine SARS-CoV-2 (inactivated) produced by Sinovac (SV) was the first
vaccine against COVID-19 to be used in Brazil. To understand the metabolic effects of SV in …
vaccine against COVID-19 to be used in Brazil. To understand the metabolic effects of SV in …
[HTML][HTML] Significant increase in anti-SARS-CoV-2 antibodies after administration of heterologous mRNA-based vaccine booster in individuals receiving two doses of …
Background Vaccine plays an important role in breaking SARS-CoV-2 transmission and
accelerating the path to pandemic recovery. Currently, there is still limited data on …
accelerating the path to pandemic recovery. Currently, there is still limited data on …
Comparison of antibody responses of heterologous and homologous Covid-19 booster vaccination: an observational study
Objective Pakistan has been seriously affected by the COVID-19 pandemic, with numerous
waves of infection. Using different vaccine and booster doses was a key component to …
waves of infection. Using different vaccine and booster doses was a key component to …
[HTML][HTML] Humoral response after a BNT162b2 heterologous third dose of COVID-19 vaccine following two doses of BBIBP-CorV among healthcare personnel in Peru
S Montero, D Urrunaga-Pastor, P Soto-Becerra… - Vaccine: X, 2023 - Elsevier
Background The inactivated virus vaccine, BBIBP-CorV, was principally distributed across
low-and middle-income countries as primary vaccination strategy to prevent poor COVID-19 …
low-and middle-income countries as primary vaccination strategy to prevent poor COVID-19 …
Short-term drop in antibody titer after the third dose of SARS-CoV-2 BNT162b2 vaccine in adults
J Herzberg, B Fischer, H Becher, AK Becker… - Vaccines, 2022 - mdpi.com
Little is known about the longevity of antibodies after a third dose of the mRNA-based SARS-
CoV-2 vaccine BNT162b2 (BioNTech/Pfizer, Mainz, Germany). Therefore, serum antibody …
CoV-2 vaccine BNT162b2 (BioNTech/Pfizer, Mainz, Germany). Therefore, serum antibody …